Structural and Functional Role of Helices I and II in Rhodopsin

The naturally occurring mutations G51A and G51V in transmembrane helix I and G89D in the transmembrane helix II of rhodopsin are associated with the retinal degenerative disease autosomal dominant retinitis pigmentosa. To probe the orientation and packing of helices I and II a number of replacements at positions 51 and 89 were prepared by using site-directed mutagenesis, and the corresponding proteins expressed in COS-1 cells were characterized. Mutations at position 51 (G51V and G51L) bound retinal like wild-type rhodopsin but had thermally destabilized structures in the dark, altered photobleaching behavior, destabilized metarhodopsin II active conformations, and were severely defective in signal transduction. The effects observed can be correlated with the size of the mutated side chains that would interfere with specific interhelical interaction with Val-300 in helix VII. Mutations at position 89 had sensitivity to charge, as in G89K and G89D mutants, which showed reduced transducin activation. G89K showed a second absorbing species in the UV region at 350 nm, suggesting a charge effect of the introduced lysine. Increased formation of non-active forms of rhodopsin, like metarhodopsin III, may have some influence in the molecular defect underlying retinitis pigmentosa in the mutants studied. At the structural level, the effect of the mutations analyzed can be rationalized assuming a very specific set of tertiary interactions in the interhelical packing of the transmembrane segments of rhodopsin.

[1]  P. Humphries,et al.  On the genetics of retinitis pigmentosa and on mutation‐independent approaches to therapeutic intervention , 2002, The EMBO journal.

[2]  A. Kowalski-Chauvel,et al.  Mutation of Asn-391 within the Conserved NPXXY Motif of the Cholecystokinin B Receptor Abolishes Gq Protein Activation without Affecting Its Association with the Receptor* , 2000, The Journal of Biological Chemistry.

[3]  K. Palczewski,et al.  Signaling States of Rhodopsin , 2003, The Journal of Biological Chemistry.

[4]  T. L. McGee,et al.  Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Farrens,et al.  Stability of Dark State Rhodopsin Is Mediated by a Conserved Ion Pair in Intradiscal Loop E-2* , 2003, The Journal of Biological Chemistry.

[6]  D. Baylor,et al.  Activation, deactivation, and adaptation in vertebrate photoreceptor cells. , 2001, Annual review of neuroscience.

[7]  H. Khorana,et al.  Structure and function in rhodopsin: replacement by alanine of cysteine residues 110 and 187, components of a conserved disulfide bond in rhodopsin, affects the light-activated metarhodopsin II state. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Towner,et al.  INVERTEBRATE VISUAL PIGMENTS , 1995, Photochemistry and photobiology.

[9]  H. Khorana,et al.  Structure and Function in Rhodopsin , 1995, The Journal of Biological Chemistry.

[10]  M. Sheves,et al.  Interactions of the beta-ionone ring with the protein in the visual pigment rhodopsin control the activation mechanism. An FTIR and fluorescence study on artificial vertebrate rhodopsins. , 1994, Biochemistry.

[11]  C. M. Davenport,et al.  Rhodopsin mutations in autosomal dominant retinitis pigmentosa. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  H. Khorana,et al.  Structure and function in rhodopsin. Separation and characterization of the correctly folded and misfolded opsins produced on expression of an opsin mutant gene containing only the native intradiscal cysteine codons. , 1995, Biochemistry.

[13]  P. Garriga,et al.  Mutations at position 125 in transmembrane helix III of rhodopsin affect the structure and signalling of the receptor. , 2001, European journal of biochemistry.

[14]  H. Khorana,et al.  Expression of a synthetic bovine rhodopsin gene in monkey kidney cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[15]  S. Miura,et al.  TM2-TM7 Interaction in Coupling Movement of Transmembrane Helices to Activation of the Angiotensin II Type-1 Receptor* , 2003, The Journal of Biological Chemistry.

[16]  S. Wodak,et al.  A Conserved Asn in Transmembrane Helix 7 Is an On/Off Switch in the Activation of the Thyrotropin Receptor* , 2001, The Journal of Biological Chemistry.

[17]  P. Hargrave Rhodopsin structure, function, and topography the Friedenwald lecture. , 2001, Investigative ophthalmology & visual science.

[18]  R. Molday,et al.  Differential immunogold-dextran labeling of bovine and frog rod and cone cells using monoclonal antibodies against bovine rhodopsin. , 1986, Experimental eye research.

[19]  E. Meyerowitz,et al.  An opsin gene that is expressed only in the R7 photoreceptor cell of Drosophila. , 1987, The EMBO journal.

[20]  H. Khorana,et al.  Role of the intradiscal domain in rhodopsin assembly and function. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Harel Weinstein,et al.  Conserved Helix 7 Tyrosine Acts as a Multistate Conformational Switch in the 5HT2C Receptor , 2002, The Journal of Biological Chemistry.

[22]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[23]  P. Garriga,et al.  The eye photoreceptor protein rhodopsin. Structural implications for retinal disease 1 , 2002, FEBS letters.

[24]  J. Gutkind,et al.  G-protein-coupled receptors and signaling networks: emerging paradigms. , 2001, Trends in pharmacological sciences.

[25]  P. Garriga,et al.  Unusual Thermal and Conformational Properties of the Rhodopsin Congenital Night Blindness Mutant Thr-94 → Ile* , 2003, The Journal of Biological Chemistry.

[26]  H. Khorana,et al.  Total synthesis of a gene for bovine rhodopsin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Molday,et al.  Monoclonal antibodies to rhodopsin: characterization, cross-reactivity, and application as structural probes. , 1983, Biochemistry.

[28]  B. Rosner,et al.  Disease progression in patients with dominant retinitis pigmentosa and rhodopsin mutations. , 2002, Investigative ophthalmology & visual science.

[29]  H. Khorana,et al.  Structure and function in rhodopsin: correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Saldanha,et al.  Seven-transmembrane receptors: crystals clarify. , 2002, Trends in pharmacological sciences.

[31]  D C Teller,et al.  Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.

[32]  S. Goldin,et al.  Purification and Characterization of Bovine Transducin and its Subunits , 1993 .

[33]  Edward N Pugh,et al.  G proteins and phototransduction. , 2002, Annual review of physiology.

[34]  Lakshmi A. Devi,et al.  G protein coupled receptor dimerization: implications in modulating receptor function , 2001, Journal of Molecular Medicine.

[35]  J. Wess G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  Yoshinori Shichida,et al.  Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Sakmar,et al.  Rhodopsin: insights from recent structural studies. , 2002, Annual review of biophysics and biomolecular structure.

[38]  E. Meng,et al.  Receptor activation: what does the rhodopsin structure tell us? , 2001, Trends in pharmacological sciences.

[39]  S. Miura,et al.  Constitutive Activation of Angiotensin II Type 1 Receptor Alters the Orientation of Transmembrane Helix-2* , 2002, The Journal of Biological Chemistry.

[40]  K. Palczewski,et al.  Activation of rhodopsin: new insights from structural and biochemical studies. , 2001, Trends in biochemical sciences.

[41]  E. Berson Retinitis pigmentosa. The Friedenwald Lecture. , 1993, Investigative ophthalmology & visual science.

[42]  P. Garriga,et al.  Zinc-induced Decrease of the Thermal Stability and Regeneration of Rhodopsin* , 2003, The Journal of Biological Chemistry.

[43]  H. Khorana,et al.  Structure and function in rhodopsin: packing of the helices in the transmembrane domain and folding to a tertiary structure in the intradiscal domain are coupled. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Khorana,et al.  A single amino acid substitution in rhodopsin (lysine 248----leucine) prevents activation of transducin. , 1988, The Journal of biological chemistry.

[45]  J. Nathans,et al.  Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P. Du,et al.  Sequence divergence analysis for the prediction of seven-helix membrane protein structures: II. A 3-D model of human rhodopsin. , 1994, Protein engineering.

[47]  C. M. Davenport,et al.  Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain. , 1993, The Journal of biological chemistry.

[48]  D. Oprian,et al.  Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness , 1994, Nature.

[49]  C. M. Davenport,et al.  Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin. , 1993, American journal of human genetics.

[50]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[51]  K. Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.

[52]  H. Khorana,et al.  Structure and function in rhodopsin: correct folding and misfolding in point mutants at and in proximity to the site of the retinitis pigmentosa mutation Leu-125-->Arg in the transmembrane helix C. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  S. O. Smith,et al.  Constitutive activation of opsin by mutation of methionine 257 on transmembrane helix 6. , 1998, Biochemistry.

[54]  Krzysztof Palczewski,et al.  Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[55]  H. Jörnvall,et al.  Cloning, structure, and expression of the mitochondrial cytochrome P-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. , 1989, The Journal of biological chemistry.

[56]  J. Bockaert,et al.  Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.

[57]  K. Fahmy,et al.  Regulation of the rhodopsin-transducin interaction by a highly conserved carboxylic acid group. , 1993, Biochemistry.

[58]  S. Kaushal,et al.  Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. , 1994, Biochemistry.